|Grant Affiliation:||Weiss: Protection by Neutralizing Antibodies|
|Strategy:||Protein & peptide vaccines|
|Study Type:||Pre-Clinical Non-NHP|
|Study Start Date:||2007-10-25|
|Study Made Public:||NA|
Screen for neutralizing antibodies induced by gp41-HA immunization
CAVD 288 is a preclinical rabbit study to assess a novel gp41 construct (HA-gp41) for its ability to induce neutralizing antibodies in rabbits.
Sign in to see full information about this study and to download study data.
ProductsProduct info coming soon!
No integrated data is available for this study.
No non-integrated data is available for this study.